Details continue to emerge about coverups and fraud that took place during Pfizer’s COVID-19 shot trials. Die Welt, a mainstream media outlet in Germany, revealed that numerous subjects who suffered adverse events, including deaths, were removed from the trial data.1,2 Meanwhile, trial data were manipulated “to create the illusion” the shot is 90% effective, for… Read More »
Pfizer’s Covid vaccine efficacy against infection plunges to just 20% after six months – but protection against severe illness barely dips, study concludes Pfizer’s protection against catching Covid drops to just 20% within six months Effectiveness against severe illness and death remains high for at least 6 months The study used data from Qatar, where… Read More »
While much of the world focused on Pfizer and BioNTech’s positive COVID-19 vaccine news on Monday, analysts started gaming out potential ripple effects, namely for companies making coronavirus therapeutics. A promising COVID-19 vaccine is obviously good news for drugmakers and the world at large, but companies developing and selling coronavirus treatments could see lower sales down the line, Barclays analysts wrote… Read More »
Pfizer’s tafamidis arrived in the U.S. in 2019 with a vastly discounted list price over rival transthyretin amyloidosis drugs. But its $ 225,000-a-year tag still seems too much for many heart patients. Previous cost-effectiveness analyses and physicians themselves have warned tafamidis is too pricey—the world’s most expensive medication for cardiovascular disease, to be exact. And now,… Read More »